125 related articles for article (PubMed ID: 4219589)
1. Effects of pretreatment of mice with BCG cell walls in saline on subsequent vaccination with BCG oil droplet vaccine.
Meyer TJ; Anacker RL; Ribi E
Cell Immunol; 1974 Oct; 14(1):52-65. PubMed ID: 4219589
[No Abstract] [Full Text] [Related]
2. Cellular regulation of lung granuloma formation and delayed- type hypersensitivity induced with BCG cell walls. Further evidence of involvement of cellular immunity in lung granuloma formation.
Yamamoto K; Kato K; Kakinuma M; Brehmer W
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Mar; 251(3):357-68. PubMed ID: 7043952
[TBL] [Abstract][Full Text] [Related]
3. [Immunity against Mycobacterium, with special reference to the experiments using BCG cell wall].
Yamamoto K
Kekkaku; 1976 May; 51(5):155-7. PubMed ID: 819704
[No Abstract] [Full Text] [Related]
4. Genetic control of granuloma response to oil-associated BCG cell wall vaccine in mice.
Yamamoto K; Karinuma M
Microbiol Immunol; 1978; 22(6):335-48. PubMed ID: 357935
[TBL] [Abstract][Full Text] [Related]
5. Biologically active components from mycobacterial cell walls. IV. Protection of mice against aerosol infection with virulent mycobacterium tuberculosis.
Ribi E; Meyer TJ; Azuma I; Parker R; Brehmer W
Cell Immunol; 1975 Mar; 16(1):1-10. PubMed ID: 803876
[No Abstract] [Full Text] [Related]
6. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis.
Olsen AW; Brandt L; Agger EM; van Pinxteren LA; Andersen P
Scand J Immunol; 2004 Sep; 60(3):273-7. PubMed ID: 15320884
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of cell walls from various mycobacteria against airborne tuberculosis in mice.
Brehmer W; Anacker RL; Ribi E
J Bacteriol; 1968 Jun; 95(6):2000-4. PubMed ID: 4970218
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous granulomatous response to BCG cell walls with reference to cancer immunotherapy.
Granger DL; Brehmer W; Brehmer W; Yamamoto K; Ribi E
Infect Immun; 1976 Feb; 13(2):543-53. PubMed ID: 770333
[TBL] [Abstract][Full Text] [Related]
9. Strain differences in lung granuloma formation in response to a BCG cell-wall vaccine in mice. Failure of antigen presentation by low-responder macrophages.
Kakinuma M; Onoé K; Yasumizu R; Yamamoto K
Immunology; 1983 Nov; 50(3):423-31. PubMed ID: 6354921
[TBL] [Abstract][Full Text] [Related]
10. [Cellular mechanism in the immune response].
Ohara T; Yamamoto K; Kakinuma M
Hokkaido Igaku Zasshi; 1979 Jan; 54(1):1-13. PubMed ID: 112017
[No Abstract] [Full Text] [Related]
11. Proceedings: Cross reactions between mycobacterial antigens.
Rees RJ
Ann Sclavo; 1971; 13(6):430-46. PubMed ID: 5005892
[No Abstract] [Full Text] [Related]
12. The relationship of delayed hypersensitivity to acquired antituberculous immunity. II. Effect of adjuvant on the allergenicity and immunogenicity of heat-killed tubercle bacilli.
Collins FM; Mackaness GB
Cell Immunol; 1970 Sep; 1(3):266-75. PubMed ID: 5002230
[No Abstract] [Full Text] [Related]
13. Biologically active components from mycobacterial cell walls. V. Granuloma formation in mouse lungs and guinea pig skin.
Meyer TJ; Ribi E; Azuma I
Cell Immunol; 1975 Mar; 16(1):11-24. PubMed ID: 803877
[No Abstract] [Full Text] [Related]
14. Intranasal bacille Calmette-Guerin (BCG) vaccine dosage needs balancing between protection and lung pathology.
Tree JA; Williams A; Clark S; Hall G; Marsh PD; Ivanyi J
Clin Exp Immunol; 2004 Dec; 138(3):405-9. PubMed ID: 15544615
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
Lu M; Xia ZY; Bao L
Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
[TBL] [Abstract][Full Text] [Related]
16. Immunization of mice by combinations of inactive fractions of Mycobacterium bovis strain BCG.
Anacker RL; Bickel WD; Brehmer W; Niwa M; Ribi E; Tarmina DF
Proc Soc Exp Biol Med; 1969 Mar; 130(3):723-30. PubMed ID: 4975293
[No Abstract] [Full Text] [Related]
17. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
[TBL] [Abstract][Full Text] [Related]
18. Strain differences in lung granuloma formation in response to a BCG cell-wall vaccine in mice. Demonstration of two types of low responders.
Kakinuma M; Yamamoto K
Immunology; 1985 May; 55(1):91-5. PubMed ID: 3997202
[TBL] [Abstract][Full Text] [Related]
19. A strategy to improve the efficacy of vaccination against tuberculosis and leprosy.
Bretscher PA
Immunol Today; 1992 Sep; 13(9):342-5. PubMed ID: 1466750
[TBL] [Abstract][Full Text] [Related]
20. Immune responses of white-tailed deer (Odocoileus virginianus) to Mycobacterium bovis BCG vaccination.
Waters WR; Palmer MV; Whipple DL; Slaughter RE; Jones SL
J Wildl Dis; 2004 Jan; 40(1):66-78. PubMed ID: 15137490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
